Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its structure allows for selective modification, making it valuable in medicinal chemistry for optimizing drug potency and selectivity. Commonly employed in research settings to design analogs with improved metabolic stability and binding affinity. Also utilized in solid-phase and combinatorial chemistry due to the presence of the tert-butyl carbamate (Boc) protecting group, which facilitates controlled deprotection and further functionalization.